4.6 Article

Design, synthesis, pharmacological and in silico screening of disubstituted-piperazine derivatives as selective and reversible MAO-A inhibitors for treatment of depression

期刊

JOURNAL OF MOLECULAR STRUCTURE
卷 1276, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.molstruc.2022.134671

关键词

Antidepressants; MAO-A; Piperazine; Drug development; Drug design

向作者/读者索取更多资源

In this study, a series of substituted benzenesulfonyl piperazine derivatives were synthesized and screened for their MAO-A and MAO-B inhibitory activity. Most of the compounds showed selective inhibition of MAO-A isoform. Compound NP4 and NP12 exhibited the strongest MAO-A inhibitory activity and also showed neuroprotective and antioxidant properties.
Monoamine oxidase-A inhibitors (MAO-AIs) are potential drug candidates for the treatment of depression. In the present study, a series of substituted benzenesulfonyl piperazine ( NP1-NP16 ) derivatives was synthesized and screened for their MAO-A and MAO-B inhibitory activity using the Amplex Red assay. Most of the synthesized compounds were found to show selective inhibition of MAO-A isoform. Compounds NP4 and compound NP12 showed the most potent MAO-A inhibitor activity with IC 50 values of 0.25 +/- 0.04 mu M and 0.46 +/- 0.02 mu M, respectively, and both the compounds were found reversible inhibitors. Compound NP4 was found most selective as an MAO-A inhibitor with a selectivity of 52 folds over the MAO-B isoform. In the cytotoxicity evaluation, the compounds were found nontoxic to SH-SY5Y cells and also exhibited neuroprotective properties. In the DPPH studies, compounds NP4 and NP12 showed free radical scavenging activity via reducing absorbance by around 50% at a concentration of 1 mM. In the in vivo Forced swimming test (FST) studies, NP4 and NP12 exhibited potential antidepressant-like behavior similar to standard drug fluoxetine while in the Tail suspension test (TST), both the compounds showed antidepressant-like activity better than the standard. The molecular docking studies further supported the results obtained in the in vitro and in vivo studies. Thus, the substituted benzenesulfonyl functionalized piperazinyl derivatives were found to be promising ligands and can be developed as new antidepressant molecules.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据